Unvaccinated Blood Transfusions: A Precautionary Measure for Safe Donations
In the ongoing debate surrounding COVID-19 vaccinations, an organization named Safe Blood is making waves by focusing on a different aspect of the issue – the safety of unvaccinated blood donors and recipients.
Safe Blood, the global leader in safe blood matching for unvaccinated donors and recipients, is expanding its operations across the United States and internationally to meet the growing demand for unvaxxed blood. The surge in demand is likely due to growing concerns about the effects of COVID-19 injections on blood, according to Dr. Clinton Ohlers, the vice president of Safe Blood.
Dr. Ohlers has confirmed that health problems with recipients of vaxxed blood transfusions have occurred, as predicted. Among the examples provided by Dr. Ohlers, multiple babies who received blood transfusions from vaxxed donors have died from myocarditis and other issues related to contaminated blood.
Scientists and medical professionals have examined vaxxed blood under a microscope and found it to be affected in every case. The changes observed in the blood samples are a cause for concern, fueling the demand for unvaxxed blood.
Despite these concerns, it is important to note that there is no credible evidence or reliable reports indicating an increase in demand for unvaccinated blood due to health concerns related to vaccinated blood. Blood donation and transfusion practices continue to follow established medical safety guidelines that do not differentiate donor blood based on vaccination status.
Current high-quality studies and public health data focus on the effectiveness and safety of COVID-19 vaccinations in preventing illness, particularly among older adults and high-risk populations. However, they do not report any issues or demand trends concerning vaccinated versus unvaccinated blood products. Vaccination remains an essential public health tool, with the medical community urging immunization to reduce disease risks.
In the face of this growing demand and the opposition from Big Pharma, Safe Blood is working tirelessly to pair blood transfusion recipients in need with unvaxxed donors whose blood has not been contaminated with mRNA injections. Dr. Clinton Ohlers discussed the efforts of Safe Blood on Conversations That Matter for The New American, shedding light on the organisation's mission and the concerns surrounding vaxxed blood transfusions.
The discussion about Safe Blood's efforts and the growing demand for unvaxxed blood was a significant topic on Conversations That Matter for The New American. As the demand for unvaxxed blood for transfusions continues to surge, Safe Blood is committed to ensuring the safety and efficacy of blood transfusions, independent of vaccine history.
- While concerns about the effects of COVID-19 vaccines on blood have led to a surge in the demand for unvaxxed blood, it's crucial to acknowledge that current high-quality studies and public health data do not report any issues or demand trends concerning vaccinated versus unvaccinated blood products.
- The health problems experienced by recipients of vaxxed blood transfusions, as confirmed by Dr. Clinton Ohlers, demonstrate the importance of Safe Blood's mission, as they strive to pair unvaxxed donors with recipients in need, ensuring the safety and efficacy of blood transfusions, regardless of vaccine history.
